Lisa Walter
Stock Analyst at RBC Capital
(2.32)
# 3,236
Out of 4,600 analysts
76
Total ratings
48.5%
Success rate
1.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintained: Buy | $30 | $8.59 | +249.24% | 10 | Jul 30, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $37 | $11.67 | +217.05% | 8 | Jul 23, 2026 | |
| MGTX MeiraGTx Holdings | Maintained: Buy | $25 → $26 | $12.29 | +111.55% | 8 | Jul 8, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $701 → $704 | $518.68 | +35.73% | 11 | Jul 7, 2026 | |
| RYTM Rhythm Pharmaceuticals | Maintained: Buy | $137 → $141 | $105.78 | +33.30% | 6 | Jul 7, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $142 → $148 | $104.33 | +41.86% | 2 | Jul 7, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $34 → $35 | $20.84 | +67.95% | 6 | Jun 29, 2026 | |
| IRD Opus Genetics | Initiated Coverage: Buy | $10 | $3.71 | +169.54% | 1 | Jun 23, 2026 | |
| FDMT 4D Molecular Therapeutics | Maintained: Buy | $35 | $10.26 | +241.13% | 24 | May 7, 2026 |
Ocular Therapeutix
Jul 30, 2026
Maintained: Buy
Price Target: $30
Current: $8.59
Upside: +249.24%
EyePoint
Jul 23, 2026
Reiterated: Buy
Price Target: $37
Current: $11.67
Upside: +217.05%
MeiraGTx Holdings
Jul 8, 2026
Maintained: Buy
Price Target: $25 → $26
Current: $12.29
Upside: +111.55%
United Therapeutics
Jul 7, 2026
Maintained: Buy
Price Target: $701 → $704
Current: $518.68
Upside: +35.73%
Rhythm Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $137 → $141
Current: $105.78
Upside: +33.30%
Mirum Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $142 → $148
Current: $104.33
Upside: +41.86%
Viridian Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $34 → $35
Current: $20.84
Upside: +67.95%
Opus Genetics
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.71
Upside: +169.54%
4D Molecular Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $35
Current: $10.26
Upside: +241.13%